Hovione has announced the appointment of former Evonik executive Jean-Luc Herbeaux as the company's new Chief Operating Officer. Herbeaux was most recently Senior VP and General Manager of Evonik's Health Care Business Line. He will be based at Hovione's headquarters in Lisbon, Portugal. Over the past few years, Hovione has been expanding production capacity at … [Read more...] about Hovione names Jean-Luc Herbeaux as Chief Operating Officer
People
2020 Charles G. Thiel Award goes to Jeff Weers
Digital RDD 2020 got underway on April 26 with the announcement of the winner of the Charles G. Thiel Award for Outstanding Research and Discovery in Respiratory Drug Delivery. In a recorded presentation accessible to registered delegates, committee member Peter Byron announced that this year's award goes to Jeffry Weers, Chief Technology Officer of Respira … [Read more...] about 2020 Charles G. Thiel Award goes to Jeff Weers
More management changes for Adherium
Less than two weeks after announcing the promotion of Mike Motion from Chief Commercial Officer to Chief Operating Officer, inhaler monitoring company Adherium has named Motion as its new CEO, replacing interim CEO Jeremy Curnock Cook. The company also announced that it has hired former Menarini Asia-Pacific CFO Anne Bell as Chief Financial Officer. In November … [Read more...] about More management changes for Adherium
BlueWillow announces appointment of Chad Costley as Chief Medical Officer
Intranasal vaccine developer BlueWillow Biologics has announced the appointment of Chad Costley as Chief Medical Officer. Costley, an Atlanta-based primary care physician, has previously served on BlueWillow's board of directors. BlueWillow, formerly known as NanoBio, has a number of intranasal vaccines based on its NanoVax technology in preclinical or Phase 1 … [Read more...] about BlueWillow announces appointment of Chad Costley as Chief Medical Officer
Adherium appoints James Ward-Lilley as Chairman of the Board following the death of Thomas Lynch
Inhaler monitoring company Adherium has named former Vectura CEO James Ward-Lilley as a director and Chairman of the Board after the recent death of Thomas Lynch, who had been Chairman since 2016. The company also promoted Mike Motion from Chief Commercial Officer, a position he had held since November 2019, to Chief Operating Officer. Prior to joining Vectura as … [Read more...] about Adherium appoints James Ward-Lilley as Chairman of the Board following the death of Thomas Lynch
Nanoform appoints Miguel Calado as Chairman of the Board
Finnish nanoparticle engineering company Nanoform has announced the beginning of a year-long process that will conclude with Miguel Calado succeeding Rabbe Klemets as Chairman of the Board. Klemets will take on an advisory role. Calado is currently Vice Chairman of the Board; he will be succeeded in that role by non-executive board member, Mads Laustsen. Prior to … [Read more...] about Nanoform appoints Miguel Calado as Chairman of the Board
Proveris Scientific announces new hires
Aerosol testing specialist Proveris Scientific has announced two new hires: Lee Dalton has joined Proveris as Director of Sales for North America, and Juan Osvaldo Moliere Velez, a mechanical engineer, has joined the company's technical service team. Dalton was most recently Sales Manager, Applied Sciences for Swedish intrument company Biotage AB. He has … [Read more...] about Proveris Scientific announces new hires
Mark Bridgewater joins Vectura as Chief Commercial Officer
Vectura has announced the appointment of Mark Bridgewater as Chief Commercial Officer, a position the company said it has created as it "continues with its strategy to become a leading inhalation specialist in the pharmaceutical services space." In February 2020, the company announced the appointment of Sharon Johnson as Executive VP for Delivery Management, another … [Read more...] about Mark Bridgewater joins Vectura as Chief Commercial Officer
Altavant Sciences appoints Howard M. Lazarus as Chief Medical Officer
Sumitovant Biopharma subsidiary Altavant Sciences has announced the appointment of Howard M. Lazarus as Chief Medical Officer, a newly created position. Lazarus was most recently Medical Expert/Executive Director in Clinical Development and Medical Affairs at Boehringer Ingelheim and was previously Director, Medical Affairs for Pulmonary Hypertension at Gilead … [Read more...] about Altavant Sciences appoints Howard M. Lazarus as Chief Medical Officer
Nanopharm adds to management team
Nanopharm CEO Jag Shur has announced the addition of three new members of the company's management team in a LinkedIn post. The new hires include two OINDP experts: Dave Farrow, who joins the company as Director of Operations, and Chris Vernall as Director of Business Development. Farrow was most recently Head of Development at Albany Molecular Research, Inc. and … [Read more...] about Nanopharm adds to management team